QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

20,995 signal articles · 495 in last 24h · 103,318 total before filter · latest 1h ago
495last 24h
2476last 7d
479● bullish (7d)
251● bearish (7d)
197publishers
AllMacro242Earnings1457M&A138Regulatory16Product4Analyst29
✕ clear all filtersticker: HIMSSentiment:bullishneutralbearishshow all (incl. clickbait)
Why Is HIMS Stock Down 13% Today?
Stocktwits6d agoneutral
Why Is HIMS Stock Down 13% Today?

The U.S. Federal Trade Commission on Wednesday sued the telehealth company over allegations it shared sensitive user health data with advertisers.

Exclusive-US FTC suing Hims & Hers for sending user health info to Meta, Snap
Reuters6d agoneutral
Exclusive-US FTC suing Hims & Hers for sending user health info to Meta, Snap

Federal Trade Commission is suing Hims & Hers ‌alleging the telehealth platform shared users' health ‌data with online advertisers despite promising privacy and engaged in ​deceptive billing and cancellation practices, an FTC spokesperson said. Hims & Hers is one of the largest telehealth players in the market for weight loss drugs.

US FTC sues Hims & Hers for sending user health info to Meta, Snap
Reuters6d agoneutral
US FTC sues Hims & Hers for sending user health info to Meta, Snap

The U.S. Federal Trade Commission sued Hims & Hers on Wednesday alleging the telehealth platform shared ‌users' health data with online advertisers, despite promising privacy, and engaged ‌in deceptive billing and cancellation practices. Hims & Hers stock added to losses after ‌the news and was ⁠trading down around 12%. ⁠The company offers telehealth appointments and prescriptions for erectile dysfunction, hair loss, and mental health medications, which it ships straight to customers.

Inflation Data, Trump-Xi Meet: What to Watch This Week
The Wall Street Journal86d agoneutral
Inflation Data, Trump-Xi Meet: What to Watch This Week

This week is peppered with potential market-moving events. Headlining are Tuesday’s inflation report, which will offer the latest glimpse of how the Iran war is affecting consumer prices, and President Trump’s long-awaited—and delayed—visit to China, with the war and tariffs likely to be central topics.